- Home
- AMPG vs RNXT Comparison
AMPG vs RNXT Comparison
Compare AMPG & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- RNXT
- Stock Information
- Founded
- AMPG 2002
- RNXT 2012
- Country
- AMPG United States
- RNXT United States
- Employees
- AMPG N/A
- RNXT N/A
- Industry
- AMPG Telecommunications Equipment
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- AMPG Telecommunications
- RNXT Health Care
- Exchange
- AMPG Nasdaq
- RNXT Nasdaq
- Market Cap
- AMPG 46.7M
- RNXT 44.6M
- IPO Year
- AMPG N/A
- RNXT 2021
- Fundamental
- Price
- AMPG $3.10
- RNXT $0.96
- Analyst Decision
- AMPG Strong Buy
- RNXT Strong Buy
- Analyst Count
- AMPG 1
- RNXT 2
- Target Price
- AMPG $5.00
- RNXT $7.25
- AVG Volume (30 Days)
- AMPG 774.6K
- RNXT 193.1K
- Earning Date
- AMPG 08-14-2025
- RNXT 08-14-2025
- Dividend Yield
- AMPG N/A
- RNXT N/A
- EPS Growth
- AMPG N/A
- RNXT N/A
- EPS
- AMPG N/A
- RNXT N/A
- Revenue
- AMPG $19,312,625.00
- RNXT $662,000.00
- Revenue This Year
- AMPG $114.55
- RNXT $3,104.65
- Revenue Next Year
- AMPG $50.00
- RNXT $301.89
- P/E Ratio
- AMPG N/A
- RNXT N/A
- Revenue Growth
- AMPG 58.04
- RNXT N/A
- 52 Week Low
- AMPG $0.64
- RNXT $0.75
- 52 Week High
- AMPG $6.43
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- AMPG 53.83
- RNXT 30.04
- Support Level
- AMPG $2.78
- RNXT $1.23
- Resistance Level
- AMPG $3.72
- RNXT $1.37
- Average True Range (ATR)
- AMPG 0.30
- RNXT 0.09
- MACD
- AMPG 0.01
- RNXT -0.01
- Stochastic Oscillator
- AMPG 47.01
- RNXT 11.77
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.